[{"Assets_0_Q2_USD":7396981000.0,"CommonStockSharesOutstanding_0_Q2_shares":103460000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":83514000.0,"NetIncomeLoss_1_Q2_USD":11292000.0,"NetIncomeLoss_2_Q2_USD":-18712000.0,"StockholdersEquity_0_Q2_USD":2823899000.0,"EarningsPerShareBasic_1_Q2_USD":0.11,"EarningsPerShareBasic_2_Q2_USD":-0.18,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":103699000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":103532000.0,"Ticker":"SYNH","CIK":"1610950","name":"SYNEOS HEALTH, INC.","OfficialName":"Syneos Health Inc. Class A Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8107202548.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190806"}]